ARTERIOSCLEROSIS OBLITERANS

This adverse event was reported 81 times

These drugs are most commonly taken by patients reporting ARTERIOSCLEROSIS OBLITERANS:

# Drug Count
0 ASPIRIN 20
1 ASPIRIN 325 MG 20
2 ASPIRIN 81 MG 20
3 LANSOPRAZOLE 11
4 CLOPIDOGREL 9
5 WARFARIN 8
6 VALSARTAN 7
7 WARFARIN SODIUM 7
8 AMLODIPINE BESYLATE 6
9 FUROSEMIDE 6
See all common drugs associated with ARTERIOSCLEROSIS OBLITERANS

ARTERIOSCLEROSIS OBLITERANS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SODIUM HYALURONATE 1 0.0012
1 GATIFLOXACIN 2 0.0011
2 ALPROSTADIL 4 0.0011
3 NIZATIDINE 1 0.0007
4 TRANDOLAPRIL TABLETS 1 0.0005
5 CILOSTAZOL 3 0.0005
6 SODIUM FERRIC GLUCONATE COMPLEX 1 0.0005
7 ATROPINE SULFATE INJECTION 1 0.0004
8 ATROPINE SULFATE MONOHYDRATE 1 0.0004
9 PERINDOPRIL ERBUMINE 2 0.0004
See all drugs enriched for association with ARTERIOSCLEROSIS OBLITERANS

ARTERIOSCLEROSIS OBLITERANS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Phosphodiesterase 3 Inhibitor [EPC] 2 0.0003
1 Calcitonin [EPC] 1 0.0003
2 Vitamin D2 Analog [EPC] 2 0.0003
3 Quinolone Antimicrobial [EPC] 2 0.0002
4 Cephalosporin Antibacterial [EPC] 1 0.0001
5 Vitamin D Analog [EPC] 2 0.0001
6 Bile Acid Sequestrant [EPC] 1 0.0001
7 Parenteral Iron Replacement [EPC] 1 0.0001
8 Prostaglandin Analog [EPC] 5 0.0001
9 Cholinesterase Inhibitor [EPC] 1 0.0001
See all drug classes enriched for association with ARTERIOSCLEROSIS OBLITERANS